Core Viewpoint - The article emphasizes the importance of state-owned enterprises (SOEs) in China to develop emerging pillar industries, guided by the principles of innovation, efficiency, and sustainability, as a strategic response to global technological competition and industrial restructuring [2][6]. Group 1: Methodology for Developing Emerging Pillar Industries - SOEs should adopt a tailored approach based on their unique attributes, focusing on specialized technology accumulation and resource endowments to avoid unrealistic ambitions and resource wastage [3][4]. - The State-owned Assets Supervision and Administration Commission (SASAC) is drafting a document to guide SOEs in cultivating emerging pillar industries, aiming for a leap in investment layout and overall optimization of state-owned economic structure during the 14th Five-Year Plan [4]. Group 2: Importance of Technological Innovation - Continuous investment in technological innovation is crucial for SOEs to establish a solid foundation for emerging pillar industries, with a target R&D intensity of 2.86% by 2025 [5]. - There is significant room for improvement in R&D investment among SOEs compared to private enterprises, particularly in key areas related to emerging pillar industries [5]. - The promotion of scenario cultivation and application is essential for maximizing the market benefits of R&D outcomes, bridging the gap between technology and market [5]. Group 3: Deepening Reforms - The article highlights the need for further reforms in SOEs to enhance their vitality and competitiveness, including improving the modern enterprise system and implementing targeted assessments [6]. - Transitioning from resource-dependent growth to innovation-driven and structural optimization is necessary for fostering new productive forces and emerging pillar industries [6]. - Systematic reforms are required to eliminate institutional barriers that hinder the development of new productive forces [6].

Investment Rating - The report maintains a "Recommended" rating for the new materials industry [1] Core Insights - The new materials sector is identified as a crucial direction for the chemical industry, currently experiencing rapid growth in downstream demand. With policy support and technological breakthroughs, domestic new materials are expected to accelerate their long-term growth. The report emphasizes that "one generation of materials leads to one generation of industries," highlighting the foundational role of the new materials industry in supporting other sectors [6][17]. Summary by Sections 1. Electronic Information Sector - Focus areas include semiconductor materials, display materials, and 5G materials [7] - In the first two months of 2026, China's total import and export value reached 7.73 trillion yuan, a year-on-year increase of 18.3%. Notably, the export value of integrated circuits reached 304.67 billion yuan, up 68.9% year-on-year [8][24]. 2. Aerospace Sector - Key materials of interest are PI films, precision ceramics, and carbon fibers [9] 3. New Energy Sector - Focus on photovoltaic materials, lithium-ion batteries, proton exchange membranes, and hydrogen storage materials [11] 4. Biotechnology Sector - Key areas include synthetic biology and scientific services [13] 5. Energy Conservation and Environmental Protection Sector - Focus on adsorbent resins, membrane materials, and biodegradable plastics [15] 6. Key Companies and Profit Forecasts - The report lists several key companies with their stock prices and earnings per share (EPS) forecasts for 2023, 2024E, and 2025E, along with their respective investment ratings [18].

Group 1: Macro Insights - The recent changes in the US economy, policy, and government strategy indicate resilience in economic growth, but internal momentum is gradually weakening, with AI investment emerging as a new growth pillar [4] - The labor market is experiencing a mild rebalancing, while inflation has significantly retreated from its peak, although service inflation remains sticky, making super core inflation a key variable for future policy direction [4] - The upcoming midterm election cycle is influencing US policy, with a cautious monetary policy stance expected in the short term, but potential for easing after leadership changes [4] Group 2: Government Work Report and "14th Five-Year Plan" - The 2026 government work report shows notable changes compared to the previous year, with a focus on economic stability and growth [7] - The "14th Five-Year Plan" emphasizes the development of emerging industries, particularly in aerospace, which is expected to accelerate under dual policy and market drivers [16] Group 3: Industry Performance - The express delivery industry is undergoing a "de-involution" phase, shifting from chaotic price wars to service quality competition, with significant price recovery expected in 2025 [10] - The domestic military industry is driven by national defense policy, geopolitical environment, and domestic military spending, with a structural growth pattern anticipated in traditional and new combat equipment [11][12] - The semiconductor cleanroom market is expected to grow due to increased domestic production capacity, with projected net profits for the leading company in this sector reaching 2.14 billion, 2.83 billion, and 3.31 billion yuan from 2025 to 2027 [15] Group 4: Company-Specific Insights - Kewan Technology (300257.SZ) is collaborating with Power Planet to develop enhanced geothermal systems, with expected net profits of 4.09 billion, 6.38 billion, and 9.50 billion yuan from 2025 to 2027 [19] - Guokewai (300672.SZ) is optimizing its gross margin through successful price increases on storage products, with projected revenues of 37.4 billion and 44.9 billion yuan for 2026 and 2027, respectively [23] - Huali Group (300979.SZ) is expected to see a profit recovery in 2025, with net profits projected at 35.70 billion and 42.14 billion yuan for 2026 and 2027 [26]

Core Viewpoint - The article emphasizes Bayer's long-term commitment to the Chinese market, highlighting its strategic investments and innovations that align with China's economic policies and development goals [1][2][3]. Group 1: Bayer's Historical Commitment to China - Bayer has been rooted in China for 144 years, marking its presence as one of the earliest multinational companies in the country [2]. - The establishment of Bayer China Limited in 1994 signified a systematic and comprehensive approach to its operations in China, evolving from trade to a full ecosystem of manufacturing, research, and innovation [2]. - Over the past three decades, Bayer has continuously increased its investment in China, including modern pharmaceutical production facilities and research centers [3]. Group 2: Recent Developments and Investments - In 2024, Bayer will launch two major research and innovation platforms in Shanghai, and by 2025, it will open a manufacturing center for crop protection products in Hangzhou with an investment exceeding 300 million RMB [3]. - As of March 2026, Bayer is expected to employ around 7,000 people in China and has established multiple supply and research centers [3]. Group 3: Alignment with Chinese Policies - Bayer's mission of "shared health and eliminating hunger" aligns with China's emphasis on biomedicine as a new pillar industry and its initiatives for rural revitalization and agricultural modernization [6][8]. - The company has successfully launched 19 innovative prescription drugs in China, reflecting its ability to synchronize with the country's drug approval processes [6]. Group 4: Innovation and Collaboration - Bayer is transitioning from merely introducing global innovations to enabling Chinese innovations to reach the world, exemplified by its partnerships with top Chinese universities and local biotech firms [11][12]. - The Bayer Co.Lab in China supports startups by providing funding, technical empowerment, and global networking opportunities, facilitating their entry into international markets [12]. Group 5: Future Outlook - Bayer aims to continue collaborating with Chinese innovation partners to build a community that benefits both China and the global market, contributing to sustainable development and national strategic goals [12].

Investment Rating - The report maintains a rating of "stronger than the market" for the defense industry [4]. Core Viewpoints - The report highlights that aerospace has been designated as an emerging pillar industry for the first time in the 2026 government work report, alongside integrated circuits, biomedicine, and the low-altitude economy, indicating increased attention and investment potential in these sectors [3][45]. - Significant investments in satellite internet and other major projects are anticipated, with scales reaching hundreds of billions or even trillions [3][46]. - The report emphasizes the importance of domestic rocket development, the overseas SpaceX/Tesla supply chain, and technological innovations in the satellite industry as key areas for investment [3][51][52]. Summary by Sections Domestic Rockets - Three core logic points are presented: 1. Macro: Strong launch capacity is a strategic high ground for major powers, similar to GPUs [4][51]. 2. Mid-level: The objective gap establishes a logic for rocket quantity inflation, with a significant increase expected within five years [4][51]. 3. Micro: The listing and financing of rocket companies will drive capacity expansion across the entire industry chain, achieving a dual boost in PE and EPS [4][51]. - Recommended companies include Feiwo Technology, Western Materials, Aerospace Power, and others [4][51]. SpaceX/Tesla Supply Chain - The report notes that overseas commercial aerospace industries, represented by SpaceX, are progressing rapidly in rocket launches, Starlink deployment, and photovoltaic construction [4][52]. - Companies to watch include Lens Technology, Yujing Co., and others [4][52]. Technological Innovations in the Satellite Industry - The report indicates that new technologies such as flexible solar wings and low-cost commercial satellites are entering a rapid development phase, with new suppliers emerging [4][56]. - Suggested companies for investment include Aerospace Electronics, Geberit, and others [4][56]. Military Industry Focus - The report suggests focusing on commercial engines, nuclear fusion, and drones, highlighting companies like Aerospace Technology, and others [4][57][58]. - The report also notes ongoing geopolitical tensions that may catalyze demand in missile, unmanned, and military trade sectors [4][58].

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical industry, indicating a positive outlook compared to the overall market performance [3][15]. Core Insights - The pharmaceutical sector experienced a decline of 2.8% this week, underperforming against the Shanghai Composite Index, which fell by 0.93% [3][4]. - The biopharmaceutical industry has been designated as a "new pillar industry" in the national government work report, signaling strong policy support for its development [3][15]. - Recent trends show an increase in the prices of bulk raw materials, suggesting potential investment opportunities in companies like Xinhecheng, Zhejiang Pharmaceutical, and Tianxin Pharmaceutical [3][23]. Market Performance - The pharmaceutical index ranked 17th among 31 sub-industries, with various segments showing mixed performance: raw materials (-3.4%), chemical preparations (-1.7%), and medical devices (-4.6%) [3][4][7]. - The overall valuation of the pharmaceutical sector stands at 30.5 times earnings, ranking 12th among 31 primary industries [3][7]. Recent Key Events Government Policy - The government work report explicitly includes biopharmaceuticals as a key industry, alongside integrated circuits and aerospace, marking a significant policy shift [3][15]. - In 2025, China is expected to approve 76 innovative drugs, with domestic innovations accounting for a substantial portion of new approvals [15]. Collaboration and Licensing - Deqi Pharmaceuticals entered a global exclusive licensing agreement with U.S.-based company for a T-cell engaging antibody, with a total transaction value exceeding $1.18 billion [16]. - Shouyao Holdings has adjusted its collaboration model for a JAK2 inhibitor, streamlining ownership and payment structures [18]. New Drug Development - Avidity reported promising clinical data for a muscle-targeting antibody-drug conjugate, showing significant efficacy in reducing mRNA levels in patients [19]. - The first patient has been dosed with a novel dual-target siRNA drug developed by Beibeite, marking its entry into clinical trials [20]. - The first patient has also been dosed with RTX-117, the first "AI+RNA" small molecule drug in China, developed by Jintai Technology [20]. Financing Activities - Aidi Pharmaceuticals plans to raise up to 1.277 billion RMB, focusing on global clinical development for an HIV integrase inhibitor [23]. Investment Recommendations - Investors are advised to monitor companies involved in raw material production and innovative drug development, including Heng Rui Medicine, BeiGene, and Aidi Pharmaceuticals [3][23].

Group 1 - The core viewpoint of the report emphasizes the continuation of a "more proactive" fiscal policy and a "moderately loose" monetary environment as outlined in the 2026 Government Work Report, indicating a policy combination of "expansive fiscal + stable monetary + strengthened debt" [15][16] - The report suggests that the bond market investment strategy should adopt a "neutral overall, with a focus on structural identification" approach, given that social financing costs may have entered an "acceptable" range [15] - It highlights the importance of capturing trading opportunities from changes in supply rhythms due to fiscal expansion in interest rate bonds, while credit bonds should focus on identifying regional and platform risks, avoiding high-risk areas, and paying attention to the issuance needs of manufacturing upgrades and technological innovation entities [15] Group 2 - The report notes that the National Development and Reform Commission plans to focus on developing six emerging pillar industries and six future industries, with the former expected to reach nearly 6 trillion yuan in output value by 2025 and potentially double to over 10 trillion yuan by 2030 [13] - The six emerging pillar industries include integrated circuits, aerospace, biomedicine, low-altitude economy, new energy storage, and intelligent robotics, while the future industries encompass quantum technology, biomanufacturing, green hydrogen energy, nuclear fusion energy, brain-computer interfaces, embodied intelligence, and 6G [13] - The report indicates that these future industries are on the brink of technological breakthroughs, suggesting that what are currently considered future industries may soon become the new emerging pillar industries [13]

Core Viewpoint - The article emphasizes that the government work report during the 2026 Two Sessions outlines a clear blueprint for economic development and policy direction, signaling numerous investment opportunities, particularly in emerging industries like biomedicine, new infrastructure represented by computing and electricity synergy, and the domestic consumer market [1]. Group 1: Biomedicine as an Emerging Pillar Industry - The government work report has prioritized the cultivation of new driving forces, specifically highlighting biomedicine as a newly added emerging pillar industry, alongside future industries like brain-computer interfaces [2][3]. - Following the announcement, the biomedicine sector saw significant gains, with the China Hong Kong Innovation Drug Index rebounding by 4.24% in a single day, and individual stocks like Jiuzhou Pharmaceutical and Rongchang Bio rising by 43.53% and 10.92%, respectively [2]. - Analysts suggest that the inclusion of biomedicine in the government report, combined with the approval of several new drugs, may lead to a recovery in the sector, supported by improved market sentiment and reduced selling pressure [3]. Group 2: Computing and Electricity Synergy as New Infrastructure - The government work report has placed significant emphasis on creating a new form of intelligent economy, particularly through the implementation of computing and electricity synergy projects as part of new infrastructure [4][5]. - The term "computing and electricity synergy" was introduced in the report, indicating a focus on integrating AI with energy resources to address structural energy supply issues, which has led to increased activity in the power and grid equipment sectors [5][6]. - The demand for high-density energy consumption driven by AI computing is expected to create substantial opportunities for equipment manufacturers, with the potential for a trillion-level market expansion in this area [6]. Group 3: Domestic Consumption Recovery - The government work report has prioritized building a strong domestic market, emphasizing the need to stimulate consumption and expand investment, which is expected to enhance domestic demand [7][8]. - Specific policies aimed at boosting consumption include a plan for urban and rural residents' income growth and the promotion of paid leave for workers, which are designed to create new consumption scenarios [8]. - Analysts predict that the combination of supply and demand-side policies will lead to a robust recovery in domestic consumption, with a focus on service consumption and effective investment potential [8][9]. Group 4: Market Outlook - Fund companies generally believe that the positive policy expectations from the Two Sessions will help boost market confidence and risk appetite, potentially leading to a new market rally driven by domestic demand and technological innovation [9][10]. - The report indicates a commitment to maintaining growth targets and policy support, which, combined with the resumption of work and production, is expected to create favorable conditions for the market [10]. - Investment strategies are suggested to focus on sectors benefiting from supply-demand improvements and economic recovery, particularly in midstream manufacturing and cyclical sectors, as well as technology-driven investment opportunities [10][11].

Core Insights - The report highlights the growth potential of six emerging pillar industries in China, including integrated circuits, aerospace, biomedicine, low-altitude economy, new energy storage, and intelligent robotics, with an expected output of nearly 6 trillion yuan by 2025 and over 10 trillion yuan by 2030 [4][7]. Domestic Market Performance - The Shanghai Composite Index closed at 4,124.19, up 0.38%, while the Shenzhen Component Index closed at 14,172.63, up 0.59% [3]. - The average P/E ratios for the Shanghai Composite and ChiNext are 16.94 and 51.73, respectively, indicating a suitable environment for medium to long-term investments [8][9]. International Market Performance - The Dow Jones closed at 30,772.79, down 0.67%, while the Nasdaq closed at 11,247.58, down 0.15% [4]. Industry Analysis - The automotive and photovoltaic sectors are leading the A-share market, with a focus on technology and cyclical sectors as the main investment themes [5][6]. - The chemical industry index rose by 5.91% in February, ranking 6th among 30 sectors, with phosphates and inorganic salts performing well [16]. - The food and beverage sector showed a slight increase, with significant growth in prepared foods and liquor, although overall performance remains weak [21][24]. Investment Strategies - The report suggests a balanced investment strategy focusing on technology and consumer sectors, while also considering opportunities in electric grid equipment, automotive parts, and chemical raw materials [10][11][15]. - The photovoltaic industry is undergoing a deep adjustment, with a focus on governance and supply-demand balance, and is expected to recover steadily after a short-term decline [25][26]. Key Data Updates - China's gold reserves increased to 7,422 million ounces (approximately 2,308.5 tons) as of the end of February, marking the 16th consecutive month of increase [5][7]. - The semiconductor sales in China reached $212.9 billion in December 2025, showing a year-on-year growth of 34.1% [31].

Core Insights - The defense budget is set to increase by 7% year-on-year, with a total of 1,909.561 billion RMB allocated for 2026, slightly down from 7.2% in 2025. Aerospace has been designated as a new emerging pillar industry for the first time [5][13] - The report emphasizes the growth potential in sectors such as large aircraft, commercial aerospace, and the overall defense industry, driven by government initiatives and strategic planning [5][14] Industry Overview - The government aims to develop emerging pillar industries including integrated circuits, aerospace, biomedicine, and low-altitude economy, with projections indicating that the output of six major emerging industries could reach 6 trillion RMB by 2025 and potentially double by 2030 [5][13] - The report highlights the importance of the C919 aircraft and other models in enhancing China's aerospace capabilities, alongside the establishment of a space data center as part of the national strategy [5][14] Investment Recommendations - The report suggests focusing on companies that align with the "S-curve" evolution, emphasizing supply chain reforms, maintenance, and trends towards automation and intelligence. Key companies include AVIC Engine, AVIC Xi'an Aircraft, and others [5][15] - It also identifies opportunities in military trade, large aircraft, and low-altitude economy, recommending companies like Guorui Technology and China Power for their growth potential in these areas [5][15] Company Valuations and Financial Analysis - AVIC Engine (600893.SH) has a target price of 44.47 RMB per share for 2025, with an expected EPS of 0.34 RMB and a PE ratio of 278.09x for 2025 [6] - China Power (600482.SH) is projected to have a target price of 26.55 RMB per share for 2025, with an expected EPS of 1.33 RMB and a PE ratio of 47.88x for 2025 [6] - Other companies such as AVIC Heavy Machinery and AVIC Xi'an Aircraft are also highlighted for their strong market positions and growth prospects in the defense sector [6][23][24]